Am J Hematol
- GLASPY J, Gabrail NY, Locantore-Ford P, Lee T, et al
Open-label, Phase 2 study of roxadustat for the treatment of anemia in patients
receiving chemotherapy for non-myeloid malignancies.
Am J Hematol. 2023 Jan 29. doi: 10.1002/ajh.26865.
Am J Obstet Gynecol
- MUNRO MG, Mast AE, Powers JM, Kouides PA, et al
The Relationship between Heavy Menstrual Bleeding, Iron Deficiency, and Iron
Deficiency Anemia.
Am J Obstet Gynecol. 2023 Jan 24:S0002-9378(23)00024.
Ann Hematol
- TANTAWY A, El-Sherif N, Makkeyah S, Eldeen NS, et al
Sleep disordered breathing and its relation to stroke and pulmonary hypertension
in children with sickle cell disease: a single-center cross-sectional study.
Ann Hematol. 2023 Jan 16. doi: 10.1007/s00277-023-05099.
- WANG H, Liu H, Li L, Chen Y, et al
Long noncoding RNA FAM157C contributes to clonal proliferation in paroxysmal
nocturnal hemoglobinuria.
Ann Hematol. 2023;102:299-309.
- FU X, Zhao X, Weng A, Zhang Q, et al
Comparative efficacy and safety of restrictive versus liberal transfusion
thresholds in anemic preterm infants: a meta-analysis of 12 randomized controlled
trials.
Ann Hematol. 2023;102:283-297.
- MELONI A, Pistoia L, Quota A, Messina G, et al
Prognostic value of multiparametric cardiac magnetic resonance in sickle cell
patients.
Ann Hematol. 2023;102:261-270.
Blood
- PARROW NL, Fleming RE
Transferrin receptor 1: keeper of HFE.
Blood. 2023;141:332-333.
- TARFI S, Badaoui B
Four genetic red cell disorders in one.
Blood. 2023;141:436.
- XIAO X, Moschetta GA, Xu Y, Fisher AL, et al
Regulation of iron homeostasis by hepatocyte TfR1 requires HFE and contributes to
hepcidin suppression in beta-thalassemia.
Blood. 2023;141:422-432.
- HULBERT ML, Fields ME, Guilliams KP, Bijlani P, et al
Normalization of cerebral hemodynamics following hematopoietic stem cell
transplant in children with sickle cell disease.
Blood. 2022 Aug 30. pii: 486449. doi: 10.1182/blood.2022016618.
BMC Cancer
- CONNOR JP, Destrampe E, Robbins D, Hess AS, et al
Pre-operative anemia and peri-operative transfusion are associated with poor
oncologic outcomes in cancers of the esophagus: potential impact of patient blood
management on cancer outcomes.
BMC Cancer. 2023;23:99.
BMJ
- KMIETOWICZ Z
Patients with sickle cell disease are let down by lack of coordinated NHS care,
report finds.
BMJ. 2023;380:257.
Haematologica
- HE Y, Guo X, Wang ZJ
Therapeutic potential of beta-lactam ceftriaxone for chronic pain in sickle cell
disease.
Haematologica. 2023;108:633-637.
- RAI P, Okhomina VI, Kang G, Akil N, et al
The effects of cardio-selective beta blockade on diastolic dysfunction in children
with sickle cell disease.
Haematologica. 2023;108:594-598.
Int J Hematol
- PIYAJAROENKIJ T, Tantiworawit A, Khikhuntod J, Piriyakhuntorn P, et al
Alteration of monocyte subsets and their functions in thalassemia patients.
Int J Hematol. 2023;117:188-197.
Lancet
- VERSTOVSEK S, Gerds AT, Vannucchi AM, Al-Ali HK, et al
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis
(MOMENTUM): results from an international, double-blind, randomised, controlled,
phase 3 study.
Lancet. 2023;401:269-280.
- IKEDA K, Ueda K
Gaining MOMENTUM against anaemic myelofibrosis.
Lancet. 2023;401:248-249.
Pediatr Rev
- TREGONING VG, Parran K, Watson AS, Mitchell ML, et al
Refractory Pneumonia in a 12-year-old Girl with Hemoglobin SS Disease.
Pediatr Rev. 2023;44:100-103.
PLoS One
- SHARIF N, Das B, Alam A
Prevalence of anemia among reproductive women in different social group in India:
Cross-sectional study using nationally representative data.
PLoS One. 2023;18:e0281015.
- TADEREGEW MM, Wondie A, Terefe TF, Tarekegn TT, et al
Anemia and its predictors among chronic kidney disease patients in Sub-Saharan
African countries: A systematic review and meta-analysis.
PLoS One. 2023;18:e0280817.
- ASMAR J, Chelala D, El Hajj Chehade R, Azar H, et al
Anemia biomarkers and mortality in hemodialysis patients with or without
diabetes: A 10-year follow-up study.
PLoS One. 2023;18:e0280871.
Transfusion
- GHESQUIERE L, Leroy J, Deken V, Tournier A, et al
Anti-RH1 alloimmunization: At what maternal antibody threshold is there a risk of
severe fetal anemia?
Transfusion. 2023 Feb 3. doi: 10.1111/trf.17264.
- TRAN A, Yan MTS, Branch DR, Blacquiere M, et al
Severe fetal anemia caused by anti-Jr(a) : Burst forming unit-erythroid colony
formation inhibition assay suggesting possible erythroid suppression mechanism.
Transfusion. 2023 Feb 2. doi: 10.1111/trf.17265.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016